Evans M - Search Results

1

Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial.

Llewelyn MJ, Budgell EP, Laskawiec-Szkonter M, Cross ELA, Alexander R, Bond S, Coles P, Conlon-Bingham G, Dymond S, Evans M, Fok R, Frost KJ, Garcia-Arias V, Glass S, Gormley C, Gray K, Hamson C, Harvey D, Hills T, Iyer S, Johnson A, Jones N, Kang P, Kiapi G, Mack D, Makanga C, Mawer D, McCullagh B, Mirfenderesky M, McEwen R, Nag S, Nagar A, Northfield J, O'Driscoll J, Pegden A, Porter R, Powell N, Price D, Sheridan E, Slatter M, Stewart B, Watson C, Weichert I, Sivyer K, Wordsworth S, Quaddy J, Santillo M, Krusche A, Roope LSJ, Mowbray F, Hand KS, Dobson M, Crook DW, Vaughan L, Hopkins S, Yardley L, Peto TEA, Walker AS. Llewelyn MJ, et al. Among authors: evans m. Lancet Infect Dis. 2023 Feb;23(2):207-221. doi: 10.1016/S1473-3099(22)00508-4. Epub 2022 Oct 4. Lancet Infect Dis. 2023. PMID: 36206793 Free article. Clinical Trial.

2

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2022 Feb 12;399(10325):665-676. doi: 10.1016/S0140-6736(22)00163-5. Lancet. 2022. PMID: 35151397 Free PMC article. Clinical Trial.

3

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0. Lancet. 2021. PMID: 33933206 Free PMC article. Clinical Trial.

4

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2021 May 29;397(10289):2049-2059. doi: 10.1016/S0140-6736(21)00897-7. Epub 2021 May 14. Lancet. 2021. PMID: 34000257 Free PMC article. Clinical Trial.

5

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2022 Jan 8;399(10320):143-151. doi: 10.1016/S0140-6736(21)01825-0. Epub 2021 Nov 17. Lancet. 2022. PMID: 34800427 Free PMC article. Clinical Trial.

6

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6. Lancet. 2022. PMID: 35908569 Free PMC article.

7

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2021 Feb 13;397(10274):605-612. doi: 10.1016/S0140-6736(21)00149-5. Epub 2021 Feb 2. Lancet. 2021. PMID: 33545096 Free PMC article. Clinical Trial.

8

Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents.

Kancharla P, Ortiz D, Fargo CM, Zhang X, Li Y, Sanchez M, Kumar A, Yeluguri M, Dodean RA, Caridha D, Madejczyk MS, Martin M, Jin X, Blount C, Chetree R, Pannone K, Dinh HT, DeLuca J, Evans M, Nadeau R, Vuong C, Leed S, Dennis WE, Roncal N, Pybus BS, Lee PJ, Roth A, Reynolds KA, Kelly JX, Landfear SM. Kancharla P, et al. Among authors: evans m. J Med Chem. 2024 May 9. doi: 10.1021/acs.jmedchem.4c00517. Online ahead of print. J Med Chem. 2024. PMID: 38722757

9

Facility- and patient-level factors associated with implementation of contact precautions in hospitalized VA patients with positive CRE cultures.

Wilson GM, Fitzpatrick M, Suda KJ, Poggensee L, Jones M, Evans ME, Evans CT. Wilson GM, et al. Among authors: evans me. Antimicrob Steward Healthc Epidemiol. 2024 May 3;4(1):e76. doi: 10.1017/ash.2024.36. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 38721489 Free PMC article.

10

Bridging the digital divide: The UNBIASED national study to unravel the impact of ethnicity and deprivation on diabetes technology disparities in the United Kingdom.

Ng SM, Evans ML, Oliver N, Rankin D, Dlugatch R, Tonga E, Darko N, Lawton J. Ng SM, et al. Among authors: evans ml. Diabet Med. 2024 May 8:e15346. doi: 10.1111/dme.15346. Online ahead of print. Diabet Med. 2024. PMID: 38718160 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,114 results

Search Page